Demographics, practice patterns and long-term outcomes of patients with non–ST-segment elevation acute coronary syndrome in the past two decades: the CREDO-Kyoto Cohort-2 and Cohort-3
ObjectivesTo evaluate patient characteristics and long-term outcomes in patients with non–ST-segment elevation acute coronary syndrome (NSTEACS) in the past two decades.DesignMulticenter retrospective study.SettingThe Coronary REvascularization Demonstrating Outcome Study in Kyoto (CREDO-Kyoto) perc...
Saved in:
Published in | BMJ open Vol. 11; no. 2; p. e044329 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
British Medical Journal Publishing Group
22.02.2021
BMJ Publishing Group LTD BMJ Publishing Group |
Series | Original research |
Subjects | |
Online Access | Get full text |
ISSN | 2044-6055 2044-6055 |
DOI | 10.1136/bmjopen-2020-044329 |
Cover
Abstract | ObjectivesTo evaluate patient characteristics and long-term outcomes in patients with non–ST-segment elevation acute coronary syndrome (NSTEACS) in the past two decades.DesignMulticenter retrospective study.SettingThe Coronary REvascularization Demonstrating Outcome Study in Kyoto (CREDO-Kyoto) percutaneous coronary intervention (PCI)/coronary artery bypass grafting (CABG) Registry Cohort-2 (2005–2007) and Cohort-3 (2011–2013).Participants3254 patients with NSTEACS who underwent first coronary revascularisation.Primary and secondary outcome measuresThe primary outcome was all-cause death. The secondary outcomes were cardiovascular death, cardiac death, sudden cardiac death, non-cardiovascular death, non-cardiac death, myocardial infarction, definite stent thrombosis, stroke, hospitalisation for heart failure, major bleeding, any coronary revascularisation and target vessel revascularisation.ResultsPatients in Cohort-3 were older and more often had heart failure at admission than those in Cohort-2. The prevalence of PCI, emergency procedure and guideline-directed medical therapy was higher in Cohort-3 than in Cohort-2. In patients who received PCI, the prevalence of transradial approach, drug-eluting stent use and intravascular ultrasound use was higher in Cohort-3 than in Cohort-2. There was no change in 3-year adjusted mortality risk from Cohort-2 to Cohort-3 (HR 1.00, 95% CI 0.83 to 1.22, p=0.97). Patients in Cohort-3 compared with those in Cohort-2 were associated with lower adjusted risks for stroke (HR 0.65, 95% CI 0.46 to 0.92, p=0.02) and any coronary revascularisation (HR 0.76, 95%CI 0.66 to 0.87, p<0.001), but with higher risk for major bleeding (HR 1.25, 95% CI 1.06 to 1.47, p=0.008). The unadjusted risk for definite stent thrombosis was lower in Cohort-3 than in Cohort 2 (HR 0.29, 95% CI 0.11 to 0.67, p=0.003).ConclusionsIn the past two decades, we did not find improvement for mortality in patients with NSTEACS. We observed a reduction in the risks for definite stent thrombosis, stroke and any coronary revascularisation, but an increase in the risk for major bleeding. |
---|---|
AbstractList | ObjectivesTo evaluate patient characteristics and long-term outcomes in patients with non–ST-segment elevation acute coronary syndrome (NSTEACS) in the past two decades.DesignMulticenter retrospective study.SettingThe Coronary REvascularization Demonstrating Outcome Study in Kyoto (CREDO-Kyoto) percutaneous coronary intervention (PCI)/coronary artery bypass grafting (CABG) Registry Cohort-2 (2005–2007) and Cohort-3 (2011–2013).Participants3254 patients with NSTEACS who underwent first coronary revascularisation.Primary and secondary outcome measuresThe primary outcome was all-cause death. The secondary outcomes were cardiovascular death, cardiac death, sudden cardiac death, non-cardiovascular death, non-cardiac death, myocardial infarction, definite stent thrombosis, stroke, hospitalisation for heart failure, major bleeding, any coronary revascularisation and target vessel revascularisation.ResultsPatients in Cohort-3 were older and more often had heart failure at admission than those in Cohort-2. The prevalence of PCI, emergency procedure and guideline-directed medical therapy was higher in Cohort-3 than in Cohort-2. In patients who received PCI, the prevalence of transradial approach, drug-eluting stent use and intravascular ultrasound use was higher in Cohort-3 than in Cohort-2. There was no change in 3-year adjusted mortality risk from Cohort-2 to Cohort-3 (HR 1.00, 95% CI 0.83 to 1.22, p=0.97). Patients in Cohort-3 compared with those in Cohort-2 were associated with lower adjusted risks for stroke (HR 0.65, 95% CI 0.46 to 0.92, p=0.02) and any coronary revascularisation (HR 0.76, 95%CI 0.66 to 0.87, p<0.001), but with higher risk for major bleeding (HR 1.25, 95% CI 1.06 to 1.47, p=0.008). The unadjusted risk for definite stent thrombosis was lower in Cohort-3 than in Cohort 2 (HR 0.29, 95% CI 0.11 to 0.67, p=0.003).ConclusionsIn the past two decades, we did not find improvement for mortality in patients with NSTEACS. We observed a reduction in the risks for definite stent thrombosis, stroke and any coronary revascularisation, but an increase in the risk for major bleeding. To evaluate patient characteristics and long-term outcomes in patients with non-ST-segment elevation acute coronary syndrome (NSTEACS) in the past two decades.OBJECTIVESTo evaluate patient characteristics and long-term outcomes in patients with non-ST-segment elevation acute coronary syndrome (NSTEACS) in the past two decades.Multicenter retrospective study.DESIGNMulticenter retrospective study.The Coronary REvascularization Demonstrating Outcome Study in Kyoto (CREDO-Kyoto) percutaneous coronary intervention (PCI)/coronary artery bypass grafting (CABG) Registry Cohort-2 (2005-2007) and Cohort-3 (2011-2013).SETTINGThe Coronary REvascularization Demonstrating Outcome Study in Kyoto (CREDO-Kyoto) percutaneous coronary intervention (PCI)/coronary artery bypass grafting (CABG) Registry Cohort-2 (2005-2007) and Cohort-3 (2011-2013).3254 patients with NSTEACS who underwent first coronary revascularisation.PARTICIPANTS3254 patients with NSTEACS who underwent first coronary revascularisation.The primary outcome was all-cause death. The secondary outcomes were cardiovascular death, cardiac death, sudden cardiac death, non-cardiovascular death, non-cardiac death, myocardial infarction, definite stent thrombosis, stroke, hospitalisation for heart failure, major bleeding, any coronary revascularisation and target vessel revascularisation.PRIMARY AND SECONDARY OUTCOME MEASURESThe primary outcome was all-cause death. The secondary outcomes were cardiovascular death, cardiac death, sudden cardiac death, non-cardiovascular death, non-cardiac death, myocardial infarction, definite stent thrombosis, stroke, hospitalisation for heart failure, major bleeding, any coronary revascularisation and target vessel revascularisation.Patients in Cohort-3 were older and more often had heart failure at admission than those in Cohort-2. The prevalence of PCI, emergency procedure and guideline-directed medical therapy was higher in Cohort-3 than in Cohort-2. In patients who received PCI, the prevalence of transradial approach, drug-eluting stent use and intravascular ultrasound use was higher in Cohort-3 than in Cohort-2. There was no change in 3-year adjusted mortality risk from Cohort-2 to Cohort-3 (HR 1.00, 95% CI 0.83 to 1.22, p=0.97). Patients in Cohort-3 compared with those in Cohort-2 were associated with lower adjusted risks for stroke (HR 0.65, 95% CI 0.46 to 0.92, p=0.02) and any coronary revascularisation (HR 0.76, 95%CI 0.66 to 0.87, p<0.001), but with higher risk for major bleeding (HR 1.25, 95% CI 1.06 to 1.47, p=0.008). The unadjusted risk for definite stent thrombosis was lower in Cohort-3 than in Cohort 2 (HR 0.29, 95% CI 0.11 to 0.67, p=0.003).RESULTSPatients in Cohort-3 were older and more often had heart failure at admission than those in Cohort-2. The prevalence of PCI, emergency procedure and guideline-directed medical therapy was higher in Cohort-3 than in Cohort-2. In patients who received PCI, the prevalence of transradial approach, drug-eluting stent use and intravascular ultrasound use was higher in Cohort-3 than in Cohort-2. There was no change in 3-year adjusted mortality risk from Cohort-2 to Cohort-3 (HR 1.00, 95% CI 0.83 to 1.22, p=0.97). Patients in Cohort-3 compared with those in Cohort-2 were associated with lower adjusted risks for stroke (HR 0.65, 95% CI 0.46 to 0.92, p=0.02) and any coronary revascularisation (HR 0.76, 95%CI 0.66 to 0.87, p<0.001), but with higher risk for major bleeding (HR 1.25, 95% CI 1.06 to 1.47, p=0.008). The unadjusted risk for definite stent thrombosis was lower in Cohort-3 than in Cohort 2 (HR 0.29, 95% CI 0.11 to 0.67, p=0.003).In the past two decades, we did not find improvement for mortality in patients with NSTEACS. We observed a reduction in the risks for definite stent thrombosis, stroke and any coronary revascularisation, but an increase in the risk for major bleeding.CONCLUSIONSIn the past two decades, we did not find improvement for mortality in patients with NSTEACS. We observed a reduction in the risks for definite stent thrombosis, stroke and any coronary revascularisation, but an increase in the risk for major bleeding. To evaluate patient characteristics and long-term outcomes in patients with non-ST-segment elevation acute coronary syndrome (NSTEACS) in the past two decades. Multicenter retrospective study. The Coronary REvascularization Demonstrating Outcome Study in Kyoto (CREDO-Kyoto) percutaneous coronary intervention (PCI)/coronary artery bypass grafting (CABG) Registry Cohort-2 (2005-2007) and Cohort-3 (2011-2013). 3254 patients with NSTEACS who underwent first coronary revascularisation. The primary outcome was all-cause death. The secondary outcomes were cardiovascular death, cardiac death, sudden cardiac death, non-cardiovascular death, non-cardiac death, myocardial infarction, definite stent thrombosis, stroke, hospitalisation for heart failure, major bleeding, any coronary revascularisation and target vessel revascularisation. Patients in Cohort-3 were older and more often had heart failure at admission than those in Cohort-2. The prevalence of PCI, emergency procedure and guideline-directed medical therapy was higher in Cohort-3 than in Cohort-2. In patients who received PCI, the prevalence of transradial approach, drug-eluting stent use and intravascular ultrasound use was higher in Cohort-3 than in Cohort-2. There was no change in 3-year adjusted mortality risk from Cohort-2 to Cohort-3 (HR 1.00, 95% CI 0.83 to 1.22, p=0.97). Patients in Cohort-3 compared with those in Cohort-2 were associated with lower adjusted risks for stroke (HR 0.65, 95% CI 0.46 to 0.92, p=0.02) and any coronary revascularisation (HR 0.76, 95%CI 0.66 to 0.87, p<0.001), but with higher risk for major bleeding (HR 1.25, 95% CI 1.06 to 1.47, p=0.008). The unadjusted risk for definite stent thrombosis was lower in Cohort-3 than in Cohort 2 (HR 0.29, 95% CI 0.11 to 0.67, p=0.003). In the past two decades, we did not find improvement for mortality in patients with NSTEACS. We observed a reduction in the risks for definite stent thrombosis, stroke and any coronary revascularisation, but an increase in the risk for major bleeding. Objectives To evaluate patient characteristics and long-term outcomes in patients with non–ST-segment elevation acute coronary syndrome (NSTEACS) in the past two decades.Design Multicenter retrospective study.Setting The Coronary REvascularization Demonstrating Outcome Study in Kyoto (CREDO-Kyoto) percutaneous coronary intervention (PCI)/coronary artery bypass grafting (CABG) Registry Cohort-2 (2005–2007) and Cohort-3 (2011–2013).Participants 3254 patients with NSTEACS who underwent first coronary revascularisation.Primary and secondary outcome measures The primary outcome was all-cause death. The secondary outcomes were cardiovascular death, cardiac death, sudden cardiac death, non-cardiovascular death, non-cardiac death, myocardial infarction, definite stent thrombosis, stroke, hospitalisation for heart failure, major bleeding, any coronary revascularisation and target vessel revascularisation.Results Patients in Cohort-3 were older and more often had heart failure at admission than those in Cohort-2. The prevalence of PCI, emergency procedure and guideline-directed medical therapy was higher in Cohort-3 than in Cohort-2. In patients who received PCI, the prevalence of transradial approach, drug-eluting stent use and intravascular ultrasound use was higher in Cohort-3 than in Cohort-2. There was no change in 3-year adjusted mortality risk from Cohort-2 to Cohort-3 (HR 1.00, 95% CI 0.83 to 1.22, p=0.97). Patients in Cohort-3 compared with those in Cohort-2 were associated with lower adjusted risks for stroke (HR 0.65, 95% CI 0.46 to 0.92, p=0.02) and any coronary revascularisation (HR 0.76, 95%CI 0.66 to 0.87, p<0.001), but with higher risk for major bleeding (HR 1.25, 95% CI 1.06 to 1.47, p=0.008). The unadjusted risk for definite stent thrombosis was lower in Cohort-3 than in Cohort 2 (HR 0.29, 95% CI 0.11 to 0.67, p=0.003).Conclusions In the past two decades, we did not find improvement for mortality in patients with NSTEACS. We observed a reduction in the risks for definite stent thrombosis, stroke and any coronary revascularisation, but an increase in the risk for major bleeding. |
Author | Taniguchi, Ryoji Ehara, Natsuhiko Sato, Yukihito Kadota, Kazushige Onodera, Tomoya Sakamoto, Hiroki Inoko, Moriaki Furukawa, Yutaka Shinoda, Eiji Takeda, Teruki Nakatsuma, Kenji Inada, Tsukasa Ishii, Katsuhisa Yamamoto, Takashi Ando, Kenji Tamura, Takashi Takeji, Yasuaki Yamaji, Kyohei Tazaki, Junichi Yamamoto, Ko Nakagawa, Yoshihisa Komiya, Tatsuhiko Soga, Yoshiharu Mutsumura-Nakano, Yukiko Shiomi, Hiroki Suwa, Satoru Kimura, Takeshi Morimoto, Takeshi Minatoya, Kenji Yoshikawa, Yusuke Shirotani, Manabu |
AuthorAffiliation | 13 Department of Cardiovascular Medicine , Hamamatsu Rosai Hospital , Hamamatsu , Shizuoka , Japan 7 Department of Cardiology , Koto Memorial Hospital , Higashiomi , Shiga , Japan 15 Department of Cardiology , Japanese Red Cross Wakayama Medical Center , Wakayama , Japan 12 Department of Cardiology , Shizuoka City Shizuoka Hospital , Shizuoka , Japan 2 Department of Clinical Epidemiology , Hyogo College of Medicine , Nishinomiya , Hyogo , Japan 5 Department of Cardiovascular Medicine , Juntendo University Shizuoka Hospital , Izunokuni , Shizuoka , Japan 8 Division of Cardiology , Kinki University School of Medicine Nara Hospital , Ikoma , Nara , Japan 14 Department of Cardiovascular Medicine , Shiga University of Medical Science , Otsu , Shiga , Japan 1 Department of Cardiovascular Medicine , Graduate School of Medicine, Kyoto University , Kyoto , Japan 17 Department of Cardiology , Shizuoka General Hospital , Shizuoka , Japan 10 Department of Cardiovascular Medicine , Kansai Denryoku Hospital , |
AuthorAffiliation_xml | – name: 18 Division of Cardiovascular surgery , Kokura Memorial Hospital , Kitakyushu , Fukuoka , Japan – name: 12 Department of Cardiology , Shizuoka City Shizuoka Hospital , Shizuoka , Japan – name: 17 Department of Cardiology , Shizuoka General Hospital , Shizuoka , Japan – name: 13 Department of Cardiovascular Medicine , Hamamatsu Rosai Hospital , Hamamatsu , Shizuoka , Japan – name: 2 Department of Clinical Epidemiology , Hyogo College of Medicine , Nishinomiya , Hyogo , Japan – name: 4 Division of Cardiology , Kokura Memorial Hospital , Kitakyushu , Fukuoka , Japan – name: 10 Department of Cardiovascular Medicine , Kansai Denryoku Hospital , Osaka , Japan – name: 9 Department of Cardiovascular Medicine , Kobe City Medical Center General Hospital , Kobe , Hyogo , Japan – name: 15 Department of Cardiology , Japanese Red Cross Wakayama Medical Center , Wakayama , Japan – name: 19 Department of Cardiology , Kurashiki Central Hospital , Kurashiki , Okayama , Japan – name: 6 Cardiovascular Center , The Tazuke Kofukai Medical Research Institute, Kitano Hospital , Osaka , Japan – name: 11 Department of Cardiovascular Medicine , Osaka Red Cross Hospital , Osaka , Japan – name: 3 Department of Cardiology , Hyogo Prefectural Amagasaki Hospital , Amagasaki , Hyogo , Japan – name: 16 Department of Cardiology , Mitsubishi Kyoto Hospital , Kyoto , Japan – name: 8 Division of Cardiology , Kinki University School of Medicine Nara Hospital , Ikoma , Nara , Japan – name: 1 Department of Cardiovascular Medicine , Graduate School of Medicine, Kyoto University , Kyoto , Japan – name: 5 Department of Cardiovascular Medicine , Juntendo University Shizuoka Hospital , Izunokuni , Shizuoka , Japan – name: 7 Department of Cardiology , Koto Memorial Hospital , Higashiomi , Shiga , Japan – name: 14 Department of Cardiovascular Medicine , Shiga University of Medical Science , Otsu , Shiga , Japan – name: 21 Department of Cardiovascular Surgery , Graduate School of Medicine, Kyoto University , Kyoto , Japan – name: 20 Department of Cardiovascular Surgery , Kurashiki Central Hospital , Kurashiki , Okayama , Japan |
Author_xml | – sequence: 1 givenname: Yasuaki surname: Takeji fullname: Takeji, Yasuaki organization: Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan – sequence: 2 givenname: Hiroki surname: Shiomi fullname: Shiomi, Hiroki organization: Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan – sequence: 3 givenname: Takeshi orcidid: 0000-0002-6844-739X surname: Morimoto fullname: Morimoto, Takeshi organization: Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan – sequence: 4 givenname: Yusuke surname: Yoshikawa fullname: Yoshikawa, Yusuke organization: Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan – sequence: 5 givenname: Ryoji surname: Taniguchi fullname: Taniguchi, Ryoji organization: Department of Cardiology, Hyogo Prefectural Amagasaki Hospital, Amagasaki, Hyogo, Japan – sequence: 6 givenname: Yukiko surname: Mutsumura-Nakano fullname: Mutsumura-Nakano, Yukiko organization: Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan – sequence: 7 givenname: Ko surname: Yamamoto fullname: Yamamoto, Ko organization: Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan – sequence: 8 givenname: Kyohei surname: Yamaji fullname: Yamaji, Kyohei organization: Division of Cardiology, Kokura Memorial Hospital, Kitakyushu, Fukuoka, Japan – sequence: 9 givenname: Junichi surname: Tazaki fullname: Tazaki, Junichi organization: Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan – sequence: 10 givenname: Satoru surname: Suwa fullname: Suwa, Satoru organization: Department of Cardiovascular Medicine, Juntendo University Shizuoka Hospital, Izunokuni, Shizuoka, Japan – sequence: 11 givenname: Moriaki surname: Inoko fullname: Inoko, Moriaki organization: Cardiovascular Center, The Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan – sequence: 12 givenname: Teruki surname: Takeda fullname: Takeda, Teruki organization: Department of Cardiology, Koto Memorial Hospital, Higashiomi, Shiga, Japan – sequence: 13 givenname: Manabu surname: Shirotani fullname: Shirotani, Manabu organization: Division of Cardiology, Kinki University School of Medicine Nara Hospital, Ikoma, Nara, Japan – sequence: 14 givenname: Natsuhiko surname: Ehara fullname: Ehara, Natsuhiko organization: Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan – sequence: 15 givenname: Katsuhisa surname: Ishii fullname: Ishii, Katsuhisa organization: Department of Cardiovascular Medicine, Kansai Denryoku Hospital, Osaka, Japan – sequence: 16 givenname: Tsukasa surname: Inada fullname: Inada, Tsukasa organization: Department of Cardiovascular Medicine, Osaka Red Cross Hospital, Osaka, Japan – sequence: 17 givenname: Tomoya surname: Onodera fullname: Onodera, Tomoya organization: Department of Cardiology, Shizuoka City Shizuoka Hospital, Shizuoka, Japan – sequence: 18 givenname: Eiji surname: Shinoda fullname: Shinoda, Eiji organization: Department of Cardiovascular Medicine, Hamamatsu Rosai Hospital, Hamamatsu, Shizuoka, Japan – sequence: 19 givenname: Takashi surname: Yamamoto fullname: Yamamoto, Takashi organization: Department of Cardiovascular Medicine, Shiga University of Medical Science, Otsu, Shiga, Japan – sequence: 20 givenname: Takashi surname: Tamura fullname: Tamura, Takashi organization: Department of Cardiology, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan – sequence: 21 givenname: Kenji surname: Nakatsuma fullname: Nakatsuma, Kenji organization: Department of Cardiology, Mitsubishi Kyoto Hospital, Kyoto, Japan – sequence: 22 givenname: Hiroki surname: Sakamoto fullname: Sakamoto, Hiroki organization: Department of Cardiology, Shizuoka General Hospital, Shizuoka, Japan – sequence: 23 givenname: Kenji surname: Ando fullname: Ando, Kenji organization: Division of Cardiology, Kokura Memorial Hospital, Kitakyushu, Fukuoka, Japan – sequence: 24 givenname: Yoshiharu surname: Soga fullname: Soga, Yoshiharu organization: Division of Cardiovascular surgery, Kokura Memorial Hospital, Kitakyushu, Fukuoka, Japan – sequence: 25 givenname: Yutaka surname: Furukawa fullname: Furukawa, Yutaka organization: Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan – sequence: 26 givenname: Yukihito surname: Sato fullname: Sato, Yukihito organization: Department of Cardiology, Hyogo Prefectural Amagasaki Hospital, Amagasaki, Hyogo, Japan – sequence: 27 givenname: Yoshihisa surname: Nakagawa fullname: Nakagawa, Yoshihisa organization: Department of Cardiovascular Medicine, Shiga University of Medical Science, Otsu, Shiga, Japan – sequence: 28 givenname: Kazushige surname: Kadota fullname: Kadota, Kazushige organization: Department of Cardiology, Kurashiki Central Hospital, Kurashiki, Okayama, Japan – sequence: 29 givenname: Tatsuhiko surname: Komiya fullname: Komiya, Tatsuhiko organization: Department of Cardiovascular Surgery, Kurashiki Central Hospital, Kurashiki, Okayama, Japan – sequence: 30 givenname: Kenji surname: Minatoya fullname: Minatoya, Kenji organization: Department of Cardiovascular Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan – sequence: 31 givenname: Takeshi orcidid: 0000-0002-5665-4076 surname: Kimura fullname: Kimura, Takeshi email: taketaka@kuhp.kyoto organization: Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33619198$$D View this record in MEDLINE/PubMed |
BookMark | eNqNUktuFDEUbKEgEkJOgIQssWFBJ_5PmwUSmgSIiBQJwtp6cbtnetRtN7Y70ey4A6fhOpwEzychySLCG9vPVeXycz0vdpx3tiheEnxICJNHl_3CD9aVFFNcYs4ZVU-KPZpXpcRC7NxZ7xYHMS5wHlwoIeizYpcxSRRR1V7x-9j2fhZgmLcmvkVDAJNaY9EAKdngIgJXo867WZm3PfJjMr63EflmBWmtSxFdt2mOsr8_P399uyijnfW5jGxnrzLCOwRmTBYZH7yDsERx6eqQRVDrUJqvrooJpWuPamugtvHdujr9enJ8Xn5Z-uTR1M99SCVdm9lu2IviaQNdtAfbeb_4_vHkYvq5PDv_dDr9cFZeyqpK5URRI1VNGBWTBleAKyxFY0EJLojilWWCCMaJbJRShFWsIZTVDWQENAqA7RenG93aw0IPoe3zI7SHVq8LPsw0hNyzzmqOsZWyMhOugFNeASVCSDCWg6pAiqz1fqM1jJe9rU3uU4Dunuj9E9fO9cxf6YnCjNBJFnizFQj-x2hj0n0bje06cNaPUVOuqBQVJVWGvn4AXfgxuNyqNYpIwvlK8NVdR7dWbhKSAWoDMMHHGGyjTZvW_5oNtp0mWK8CqbeB1KtA6k0gM5c94N7IP8463LDy4X8Sjv4Rbh_5GOMvLHAF0A |
CitedBy_id | crossref_primary_10_1253_circrep_CR_23_0029 crossref_primary_10_1136_bmjopen_2020_043683 crossref_primary_10_15829_1728_8800_2024_3994 crossref_primary_10_1186_s12872_025_04656_1 crossref_primary_10_36660_abc_20220248 crossref_primary_10_1253_circj_CJ_22_0517 crossref_primary_10_15829_1560_4071_2024_5623 |
Cites_doi | 10.1016/j.amjcard.2015.03.059 10.1016/j.jacc.2015.04.017 10.1161/01.CIR.0000112577.69066.CB 10.1056/NEJMoa1908419 10.4244/EIJV10I1A11 10.1016/j.jacc.2018.09.013 10.1161/CIRCULATIONAHA.117.030798 10.1093/eurheartj/ehv320 10.1161/CIRCULATIONAHA.107.735902 10.1161/HCQ.0000000000000032 10.1001/jama.2019.8145 10.1016/j.ahj.2008.07.030 10.1016/S0140-6736(01)06411-X 10.1016/S0140-6736(11)60404-2 10.1016/j.jacc.2014.09.017 10.1136/hrt.2006.112847 10.1007/s12928-011-0065-0 10.1016/j.jacc.2016.03.599 10.1001/jama.297.17.1892 10.1016/j.ijcard.2014.09.023 |
ContentType | Journal Article |
Copyright | Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 |
Copyright_xml | – notice: Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. – notice: 2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 |
CorporateAuthor | CREDO-Kyoto PCI/CABG Registry Cohort-2 and the CREDO-Kyoto PCI/CABG Registry Cohort-3 Investigators |
CorporateAuthor_xml | – name: CREDO-Kyoto PCI/CABG Registry Cohort-2 and the CREDO-Kyoto PCI/CABG Registry Cohort-3 Investigators |
DBID | 9YT ACMMV AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88E 88G 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR BTHHO CCPQU DWQXO FYUFA GHDGH GNUQQ K9- K9. KB0 M0R M0S M1P M2M NAPCQ PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 5PM DOA |
DOI | 10.1136/bmjopen-2020-044329 |
DatabaseName | BMJ Open Access Journals BMJ Journals:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) ProQuest Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central BMJ Journals ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Consumer Health Database ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Consumer Health Database Health & Medical Collection (Alumni) Medical Database Psychology Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Family Health (Alumni Edition) ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition BMJ Journals ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Open Access Full Text url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: ACMMV name: BMJ Journals:Open Access url: https://journals.bmj.com/ sourceTypes: Publisher – sequence: 5 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2044-6055 |
ExternalDocumentID | oai_doaj_org_article_400e668c749a4248a21556ace4a98a65 PMC7903127 33619198 10_1136_bmjopen_2020_044329 bmjopen |
Genre | Research Support, Non-U.S. Gov't Multicenter Study Journal Article |
GeographicLocations | Japan |
GeographicLocations_xml | – name: Japan |
GrantInformation_xml | – fundername: The Research Institute for Production Development (Kyoto, Japan) grantid: Not applicable – fundername: The Pharmaceuticals and Medical Devices Agency (PMDA) in Japan (Tokyo, Japan) grantid: Not applicable – fundername: ; grantid: Not applicable |
GroupedDBID | --- 4.4 53G 5VS 7RV 7X7 7~R 88E 8FI 8FJ 9YT ABUWG ACGFS ACMMV ADBBV AENEX AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BKNYI BPHCQ BTFSW BTHHO CCPQU DIK DWQXO EBS FYUFA GNUQQ GROUPED_DOAJ GX1 H13 HMCUK HYE HZ~ K9- KQ8 M0R M1P M2M M48 M~E NAPCQ O9- OK1 PGMZT PHGZT PIMPY PQQKQ PROAC PSQYO PSYQQ RHI RMJ RPM UKHRP AAYXX ADRAZ BVXVI CITATION EJD PHGZM CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS Q9U 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-b688t-792c69d13257f08a08065fea95451948e35153416f9991383f123dfaea9af9aa3 |
IEDL.DBID | 9YT |
ISSN | 2044-6055 |
IngestDate | Wed Aug 27 01:25:10 EDT 2025 Thu Aug 21 14:20:37 EDT 2025 Fri Sep 05 06:25:07 EDT 2025 Fri Jul 25 21:20:56 EDT 2025 Thu Apr 03 06:53:03 EDT 2025 Tue Jul 01 03:00:40 EDT 2025 Thu Apr 24 22:56:42 EDT 2025 Thu Apr 24 22:50:29 EDT 2025 Thu Apr 24 22:50:35 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | coronary intervention coronary heart disease myocardial infarction |
Language | English |
License | This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b688t-792c69d13257f08a08065fea95451948e35153416f9991383f123dfaea9af9aa3 |
Notes | Original research ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-6844-739X 0000-0002-5665-4076 |
OpenAccessLink | http://dx.doi.org/10.1136/bmjopen-2020-044329 |
PMID | 33619198 |
PQID | 2492161447 |
PQPubID | 2040975 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_400e668c749a4248a21556ace4a98a65 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7903127 proquest_miscellaneous_2492658218 proquest_journals_2492161447 pubmed_primary_33619198 crossref_citationtrail_10_1136_bmjopen_2020_044329 crossref_primary_10_1136_bmjopen_2020_044329 bmj_primary_10_1136_bmjopen_2020_044329 bmj_journals_10_1136_bmjopen_2020_044329 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-02-22 |
PublicationDateYYYYMMDD | 2021-02-22 |
PublicationDate_xml | – month: 02 year: 2021 text: 2021-02-22 day: 22 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London – name: BMA House, Tavistock Square, London, WC1H 9JR |
PublicationSeriesTitle | Original research |
PublicationTitle | BMJ open |
PublicationTitleAbbrev | BMJ Open |
PublicationTitleAlternate | BMJ Open |
PublicationYear | 2021 |
Publisher | British Medical Journal Publishing Group BMJ Publishing Group LTD BMJ Publishing Group |
Publisher_xml | – name: British Medical Journal Publishing Group – name: BMJ Publishing Group LTD – name: BMJ Publishing Group |
References | Kimura, Morimoto, Furukawa (R6) 2011; 26 Jolly, Yusuf, Cairns (R11) 2011; 377 Watanabe, Domei, Morimoto (R19) 2019; 321 Roffi, Patrono, Collet (R10) 2016; 37 Fox, Steg, Eagle (R2) 2007; 297 Rogers, Frederick, Stoehr (R3) 2008; 156 Jneid, Addison, Bhatt (R9) 2017; 10 Nallamothu, Fox, Kennelly (R16) 2007; 93 Palmerini, Benedetto, Biondi-Zoccai (R13) 2015; 65 Rodriguez, Mahaffey (R1) 2016; 68 Pedersen, Pfisterer, Kaiser (R12) 2014; 10 Toyota, Shiomi, Morimoto (R18) 2015; 116 Puymirat, Simon, Cayla (R5) 2017; 136 Mukherjee, Fang, Chetcuti (R15) 2004; 109 Kimura, Morimoto, Furukawa (R7) 2008; 118 Zhang, Gao, Kan (R14) 2018; 72 Staessen, Wang, Thijs (R17) 2001; 358 Mehran, Baber, Sharma (R20) 2019; 381 Amsterdam, Wenger, Brindis (R8) 2014; 64 Puymirat, Schiele, Steg (R4) 2014; 177 Toyota, Shiomi, Morimoto 2015; 116 Puymirat, Simon, Cayla 2017; 136 Staessen, Wang, Thijs 2001; 358 Nallamothu, Fox, Kennelly 2007; 93 Rodriguez, Mahaffey 2016; 68 Kimura, Morimoto, Furukawa 2011; 26 Jolly, Yusuf, Cairns 2011; 377 Palmerini, Benedetto, Biondi-Zoccai 2015; 65 Roffi, Patrono, Collet 2016; 37 Mehran, Baber, Sharma 2019; 381 Watanabe, Domei, Morimoto 2019; 321 Kimura, Morimoto, Furukawa 2008; 118 Amsterdam, Wenger, Brindis 2014; 64 Mukherjee, Fang, Chetcuti 2004; 109 Puymirat, Schiele, Steg 2014; 177 Pedersen, Pfisterer, Kaiser 2014; 10 Rogers, Frederick, Stoehr 2008; 156 Jneid, Addison, Bhatt 2017; 10 Fox, Steg, Eagle 2007; 297 Zhang, Gao, Kan 2018; 72 Watanabe (2021022208402961000_11.2.e044329.19) 2019; 321 2021022208402961000_11.2.e044329.7 2021022208402961000_11.2.e044329.8 2021022208402961000_11.2.e044329.5 2021022208402961000_11.2.e044329.6 2021022208402961000_11.2.e044329.10 2021022208402961000_11.2.e044329.11 Toyota (2021022208402961000_11.2.e044329.18) 2015; 116 2021022208402961000_11.2.e044329.12 2021022208402961000_11.2.e044329.13 2021022208402961000_11.2.e044329.3 2021022208402961000_11.2.e044329.4 2021022208402961000_11.2.e044329.1 2021022208402961000_11.2.e044329.2 Jneid (2021022208402961000_11.2.e044329.9) 2017; 10 Mehran (2021022208402961000_11.2.e044329.20) 2019; 381 2021022208402961000_11.2.e044329.14 2021022208402961000_11.2.e044329.15 2021022208402961000_11.2.e044329.16 2021022208402961000_11.2.e044329.17 |
References_xml | – volume: 116 start-page: 187 year: 2015 ident: R18 article-title: Meta-analysis of long-term clinical outcomes of everolimus-eluting stents publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2015.03.059 – volume: 65 start-page: 2496 year: 2015 ident: R13 article-title: Long-term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2015.04.017 – volume: 109 start-page: 745 year: 2004 ident: R15 article-title: Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes publication-title: Circulation doi: 10.1161/01.CIR.0000112577.69066.CB – volume: 381 start-page: 2032 year: 2019 ident: R20 article-title: Ticagrelor with or without aspirin in high-risk patients after PCI publication-title: N Engl J Med doi: 10.1056/NEJMoa1908419 – volume: 10 start-page: 58 year: 2014 ident: R12 article-title: Drug-eluting stents and bare metal stents in patients with NSTE-ACS: 2-year outcome from the randomised BASKET-PROVE trial publication-title: EuroIntervention doi: 10.4244/EIJV10I1A11 – volume: 72 start-page: 3126 year: 2018 ident: R14 article-title: Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation: The ULTIMATE Trial publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2018.09.013 – volume: 136 start-page: 1908 year: 2017 ident: R5 article-title: Acute myocardial infarction: changes in patient characteristics, management, and 6-month outcomes over a period of 20 years in the FAST-MI program (French registry of acute ST-elevation or non-ST-elevation myocardial infarction) 1995 to 2015 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.117.030798 – volume: 37 start-page: 267 year: 2016 ident: R10 article-title: 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of cardiology (ESC) publication-title: Eur Heart J doi: 10.1093/eurheartj/ehv320 – volume: 118 start-page: S199 year: 2008 ident: R7 article-title: Long-term outcomes of coronary-artery bypass graft surgery versus percutaneous coronary intervention for multivessel coronary artery disease in the bare-metal stent era publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.107.735902 – volume: 10 year: 2017 ident: R9 article-title: 2017 AHA/ACC clinical performance and quality measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American heart association Task force on performance measures publication-title: Circ Cardiovasc Qual Outcomes doi: 10.1161/HCQ.0000000000000032 – volume: 321 start-page: 2414 year: 2019 ident: R19 article-title: Effect of 1-Month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: the STOPDAPT-2 randomized clinical trial publication-title: JAMA doi: 10.1001/jama.2019.8145 – volume: 156 start-page: 1026 year: 2008 ident: R3 article-title: Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of myocardial infarction from 1990 to 2006 publication-title: Am Heart J doi: 10.1016/j.ahj.2008.07.030 – volume: 358 start-page: 1305 year: 2001 ident: R17 article-title: Cardiovascular protection and blood pressure reduction: a meta-analysis publication-title: Lancet doi: 10.1016/S0140-6736(01)06411-X – volume: 377 start-page: 1409 year: 2011 ident: R11 article-title: Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial publication-title: Lancet doi: 10.1016/S0140-6736(11)60404-2 – volume: 64 start-page: e139 year: 2014 ident: R8 article-title: 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American heart association Task force on practice guidelines publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2014.09.017 – volume: 93 start-page: 1552 year: 2007 ident: R16 article-title: Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention. The global registry of acute coronary events publication-title: Heart doi: 10.1136/hrt.2006.112847 – volume: 26 start-page: 234 year: 2011 ident: R6 article-title: Long-term safety and efficacy of sirolimus-eluting stents versus bare-metal stents in real world clinical practice in Japan publication-title: Cardiovasc Interv Ther doi: 10.1007/s12928-011-0065-0 – volume: 68 start-page: 313 year: 2016 ident: R1 article-title: Management of patients with NSTE-ACS: a comparison of the recent AHA/ACC and ESC guidelines publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2016.03.599 – volume: 297 start-page: 1892 year: 2007 ident: R2 article-title: Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006 publication-title: JAMA doi: 10.1001/jama.297.17.1892 – volume: 177 start-page: 281 year: 2014 ident: R4 article-title: Determinants of improved one-year survival in non-ST-segment elevation myocardial infarction patients: insights from the French FAST-MI program over 15 years publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2014.09.023 – volume: 116 start-page: 187 year: 2015 article-title: Meta-analysis of long-term clinical outcomes of everolimus-eluting stents publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2015.03.059 – volume: 26 start-page: 234 year: 2011 article-title: Long-term safety and efficacy of sirolimus-eluting stents versus bare-metal stents in real world clinical practice in Japan publication-title: Cardiovasc Interv Ther doi: 10.1007/s12928-011-0065-0 – volume: 64 start-page: e139 year: 2014 article-title: 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American heart association Task force on practice guidelines publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2014.09.017 – volume: 93 start-page: 1552 year: 2007 article-title: Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention. The global registry of acute coronary events publication-title: Heart doi: 10.1136/hrt.2006.112847 – volume: 37 start-page: 267 year: 2016 article-title: 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of cardiology (ESC) publication-title: Eur Heart J doi: 10.1093/eurheartj/ehv320 – volume: 377 start-page: 1409 year: 2011 article-title: Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial publication-title: Lancet doi: 10.1016/S0140-6736(11)60404-2 – volume: 381 start-page: 2032 year: 2019 article-title: Ticagrelor with or without aspirin in high-risk patients after PCI publication-title: N Engl J Med doi: 10.1056/NEJMoa1908419 – volume: 10 year: 2017 article-title: 2017 AHA/ACC clinical performance and quality measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American heart association Task force on performance measures publication-title: Circ Cardiovasc Qual Outcomes doi: 10.1161/HCQ.0000000000000032 – volume: 109 start-page: 745 year: 2004 article-title: Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes publication-title: Circulation doi: 10.1161/01.CIR.0000112577.69066.CB – volume: 321 start-page: 2414 year: 2019 article-title: Effect of 1-Month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: the STOPDAPT-2 randomized clinical trial publication-title: JAMA doi: 10.1001/jama.2019.8145 – volume: 68 start-page: 313 year: 2016 article-title: Management of patients with NSTE-ACS: a comparison of the recent AHA/ACC and ESC guidelines publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2016.03.599 – volume: 358 start-page: 1305 year: 2001 article-title: Cardiovascular protection and blood pressure reduction: a meta-analysis publication-title: Lancet doi: 10.1016/S0140-6736(01)06411-X – volume: 72 start-page: 3126 year: 2018 article-title: Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation: The ULTIMATE Trial publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2018.09.013 – volume: 297 start-page: 1892 year: 2007 article-title: Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006 publication-title: JAMA doi: 10.1001/jama.297.17.1892 – volume: 156 start-page: 1026 year: 2008 article-title: Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of myocardial infarction from 1990 to 2006 publication-title: Am Heart J doi: 10.1016/j.ahj.2008.07.030 – volume: 136 start-page: 1908 year: 2017 article-title: Acute myocardial infarction: changes in patient characteristics, management, and 6-month outcomes over a period of 20 years in the FAST-MI program (French registry of acute ST-elevation or non-ST-elevation myocardial infarction) 1995 to 2015 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.117.030798 – volume: 177 start-page: 281 year: 2014 article-title: Determinants of improved one-year survival in non-ST-segment elevation myocardial infarction patients: insights from the French FAST-MI program over 15 years publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2014.09.023 – volume: 118 start-page: S199 year: 2008 article-title: Long-term outcomes of coronary-artery bypass graft surgery versus percutaneous coronary intervention for multivessel coronary artery disease in the bare-metal stent era publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.107.735902 – volume: 10 start-page: 58 year: 2014 article-title: Drug-eluting stents and bare metal stents in patients with NSTE-ACS: 2-year outcome from the randomised BASKET-PROVE trial publication-title: EuroIntervention doi: 10.4244/EIJV10I1A11 – volume: 65 start-page: 2496 year: 2015 article-title: Long-term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2015.04.017 – volume: 10 year: 2017 ident: 2021022208402961000_11.2.e044329.9 article-title: 2017 AHA/ACC clinical performance and quality measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American heart association Task force on performance measures publication-title: Circ Cardiovasc Qual Outcomes doi: 10.1161/HCQ.0000000000000032 – ident: 2021022208402961000_11.2.e044329.4 doi: 10.1016/j.ijcard.2014.09.023 – ident: 2021022208402961000_11.2.e044329.6 doi: 10.1007/s12928-011-0065-0 – ident: 2021022208402961000_11.2.e044329.7 doi: 10.1161/CIRCULATIONAHA.107.735902 – ident: 2021022208402961000_11.2.e044329.5 doi: 10.1161/CIRCULATIONAHA.117.030798 – ident: 2021022208402961000_11.2.e044329.11 doi: 10.1016/S0140-6736(11)60404-2 – ident: 2021022208402961000_11.2.e044329.16 doi: 10.1136/hrt.2006.112847 – ident: 2021022208402961000_11.2.e044329.2 doi: 10.1001/jama.297.17.1892 – ident: 2021022208402961000_11.2.e044329.10 doi: 10.1093/eurheartj/ehv320 – ident: 2021022208402961000_11.2.e044329.17 doi: 10.1016/S0140-6736(01)06411-X – volume: 116 start-page: 187 year: 2015 ident: 2021022208402961000_11.2.e044329.18 article-title: Meta-analysis of long-term clinical outcomes of everolimus-eluting stents publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2015.03.059 – volume: 381 start-page: 2032 year: 2019 ident: 2021022208402961000_11.2.e044329.20 article-title: Ticagrelor with or without aspirin in high-risk patients after PCI publication-title: N Engl J Med doi: 10.1056/NEJMoa1908419 – ident: 2021022208402961000_11.2.e044329.12 doi: 10.4244/EIJV10I1A11 – ident: 2021022208402961000_11.2.e044329.3 doi: 10.1016/j.ahj.2008.07.030 – ident: 2021022208402961000_11.2.e044329.1 doi: 10.1016/j.jacc.2016.03.599 – ident: 2021022208402961000_11.2.e044329.13 doi: 10.1016/j.jacc.2015.04.017 – ident: 2021022208402961000_11.2.e044329.15 doi: 10.1161/01.CIR.0000112577.69066.CB – ident: 2021022208402961000_11.2.e044329.8 doi: 10.1016/j.jacc.2014.09.017 – ident: 2021022208402961000_11.2.e044329.14 doi: 10.1016/j.jacc.2018.09.013 – volume: 321 start-page: 2414 year: 2019 ident: 2021022208402961000_11.2.e044329.19 article-title: Effect of 1-Month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: the STOPDAPT-2 randomized clinical trial publication-title: JAMA doi: 10.1001/jama.2019.8145 |
SSID | ssj0000459552 |
Score | 2.2828214 |
Snippet | ObjectivesTo evaluate patient characteristics and long-term outcomes in patients with non–ST-segment elevation acute coronary syndrome (NSTEACS) in the past... To evaluate patient characteristics and long-term outcomes in patients with non-ST-segment elevation acute coronary syndrome (NSTEACS) in the past two decades.... To evaluate patient characteristics and long-term outcomes in patients with non-ST-segment elevation acute coronary syndrome (NSTEACS) in the past two... Objectives To evaluate patient characteristics and long-term outcomes in patients with non–ST-segment elevation acute coronary syndrome (NSTEACS) in the past... |
SourceID | doaj pubmedcentral proquest pubmed crossref bmj |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | e044329 |
SubjectTerms | Acute Coronary Syndrome - surgery Acute coronary syndromes Anemia Angioplasty Biomarkers Blood pressure Body mass index Cardiovascular disease Cardiovascular Medicine Clinical outcomes Coronary Artery Disease - surgery coronary heart disease coronary intervention Coronary vessels Demographics Demography Diabetes Drug-Eluting Stents Heart attacks Heart failure Heart surgery Hemodialysis Humans Hypertension myocardial infarction Outcome Assessment, Health Care Percutaneous Coronary Intervention Retrospective Studies Risk Factors Stents Stroke Thrombosis Treatment Outcome Variables |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELagB8QF8U-gICMhwaFWE__F5gbbVhWoIEEr9RY5id1u1SZVkxXqjXfgaXgdnoQZJ7vsIlQ4cIztJE7mi-ebePyZkBeqzDmvVWC5Lx0EKGVgRjjJMhdSVeual1Hsee-D3j2Q7w7V4dJWX5gTNsgDDy9uEzDmtTZVLq2TXBoHPkppV3nprHE6qpemNl0KpuIYLJVVio8yQ5nQm-XZCe5HBajgmM8oBZLK61C64pCibv-fyObvOZNLTmjnNrk1skf6Zuj1HXLNN3fJjb1xfvwe-b7lzwYN6mnVbdD5Eih6HlU0m466pqanbXPEcESm7awHwPmOtoGOAqsdxT-ztGmbH1-_fd5nnT_C_4cUl6FHI1JXzXpPK1Q-cBeXdC55QKcNBTIJ1-l62n9pae0x9b57HUsnn7a3PrL3l23f0kl7DJyf8diZ8UDcJwc72_uTXTZuzsBKbUzPcssrbWsIZlUeUuNSnKEN3lmFgjXSeAFMCVykDkhBIQ4O4CPr4KCFC9Y58YCswbP4R4QKblKfWlOWdS21ssAgvMi4DjwH9umyhLwCOxXjx9UVMW4RuhhNWqBJi8GkCXmJTc8HpY6rW_K52YtqlEPHXTlOrz5pY3HSP93jLeJp0RSlvGMBALwYAV78DeAJWZ-j8dcrQJ3HDGP5PCHPF9UwMuB0j2t8OxvaaFwHbRLycADvoidCQOCcWajJV2C90tXVmmZ6HNXHcwt-gOeP_8ezPSE3OeYIoUQAXydr_cXMPwWS15fP4vf8E3qpTmQ priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1fb9MwELfYJiFeEP8pG8hISPCwaI0dOzYviHWdJtAGGpu0t8hJ7K5oi7smFdob34FPw9fhk3CXuB1FqOKxttO6ufP5d-fz7wh5JfKUsVK4KLW5AQcld5HiJoli4_qilCXLW7LnwyN5cJp8OBNnIeBWh7TKuU1sDXXpC4yR7yCzXYzeS_puchVh1Sg8XQ0lNNbIBphgBXq-sTs8-ny8iLIAYNFCsEA3FHO5k19-xbpUoB0M8xoTjuByDVqXNqaWv_9foPPv3Mk_NqP9e-RuQJH0fSf2--SWrR6Q24fhnPwh-blnLzsu6nFRb9P5VSg6adk0q5qaqqQXvhpFaJmpnzXwEmxNvaOBaLWmGKGlla9-ff_x5SSq7QjjiBSvo7fCpKaYNZYWyIBgptd0Tn1AxxUFUAnfUze0-eZpaTEFv37btg6Oh3ufoo_XvvF04M8B-0esnUz4wB-R0_3hyeAgCkUaolwq1USpZoXUJTi1InV9Zfp4Uuus0QKJaxJlOSAm2CqlQygK_rCDvbJ0BkYYp43hj8k6_Bf7lFDOVN_2tcrzskyk0IAkLI-ZdCwFFGriHnkDcsrCIquz1n_hMgsizVCkWSfSHnmNQycdY8fqkWwu9qwItOhYneNi9UPbi4f-6zd2UZ8WQ5HSu23w01EWLEQGxtRKqYo00SZhiTIAxoQ0hU2MVkaKHtmaa-PNK7hZFT3yctENFgKPfUxl_awbI_E-tOqRJ53yLmbCOTjQsYaedEmtl6a63FONz1sW8lTDfsDSZ6untUnuMMwCQhIAtkXWm-nMPgcY1-Qvwlr9DRMxSEI priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1fb9MwELfGkBAviP8rDGQkJHiYoXVix0ZCCLpNE6ggwSrtLXISuyvqktGkgr7xHfg0fB0-CXeOUyga0x5rX1LHd7n7XWz_jpDHIks4L4Rjic0MJCiZYyoyMRsY1xeFLHjmyZ5H7-XBOH57JI42SFcVNUxgfWZqh_WkxvPZs29flq_ghX8ZKpI8z04-YxconONWxTji-hK5DKFJYjY2Cnjfu-ZYaOGr8HCQYwDlRWAi-s99IOJA61rM8tT-Z-HRf7dV_hWn9q-TawFg0tetRdwgG7a8Sa6MwhL6LfJz1560NNXTvN6h3SkpeuqJNsuamrKgs6qcMHTatFo0YJO2ppWjgYO1pvjxlpZV-ev7j0-HrLYT_MRI8aS61zM1-aKxNEdyBDNf0o4VgU5LCngT7lM3tPla0cLi7vz6hW8dftzb_cDeLaumosPqGDTCuB9M-BHdJuP9vcPhAQv1G1gmlWpYonkudQH5rkhcX5k-LuI6a7RATptY2QjAFERR6RClQqrsIIwWzoCEcdqY6A7ZhGexW4RGXPVtX6ssK4pYCg0gw0YDLh1PAKCaQY88BT2lnfmkPrWJZBpUmqJK01alPfIERU9bMo_zJXmn9jQPjOlYuGN2_kU7q4su9B9v0J5Wosj27Ruq-SQNziMFP2ulVHkSaxPzWBnAaUKa3MZGKyNFj2x31vhnCpAKcoDpftIjj1bd4DxwRciUtlq0MhKPSqseudsa72okUQS59UBDT7Jm1mtDXe8pp8eeoDzRECp4cu_CM32fXOW4VwipAvg22WzmC_sAwF6TPfQv8G8kL1A4 priority: 102 providerName: Scholars Portal |
Title | Demographics, practice patterns and long-term outcomes of patients with non–ST-segment elevation acute coronary syndrome in the past two decades: the CREDO-Kyoto Cohort-2 and Cohort-3 |
URI | https://bmjopen.bmj.com/content/11/2/e044329.full https://www.ncbi.nlm.nih.gov/pubmed/33619198 https://www.proquest.com/docview/2492161447 https://www.proquest.com/docview/2492658218 https://pubmed.ncbi.nlm.nih.gov/PMC7903127 https://doaj.org/article/400e668c749a4248a21556ace4a98a65 |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NbtQwELZoKyEuiH8WyspISHBoxMaO_7i12y0VaAsqLVpOkZPY7aI2qZqsUG-8A0_D6_AkzDjZpYug6iVR7EnWm5l4vvHPN4S8EJlirBA-Ui6zEKBkPtLcJlFs_UAUsmBZIHse78ndw-TdREwubVZfnsGPuXydnX7FRFKgToYLERPOzApZQ1aWkLDgy8FiSAXQiREhxw4DuQiAuuh4hv7zHPAnULrkkQJx_7_Q5t-LJi95oZ075HYHH-lmq--75IYr75Gb426C_D75ue1OWxLqaV5v0PkeKHoWaDTLmtqyoCdVeRRhl0yrWQMW52paedoxrNYUh2ZpWZW_vv_4dBDV7ggHECnuQw9apDafNY7mSH1gzy_onPOATksKaBKeUze0-VbRwuHa-_pNKB3uj7Y_RO8vqqaiw-oYQH_EQmO6C_6AHO6MDoa7UZedIcqk1k2kDMulKSCaFcoPtB3gFK131ghkrEm04wCVwEdKjxgUAmEPTrLwFiSsN9byh2QV_ot7TChneuAGRmdZUSRSGIAQjsdMeqYAftq4R16BntLu66rTELhwmXYqTVGlaavSHnmJomctVcfVkmyu9jTv-NAxLcfJ1TdtLG661m9soT0tRJHLOxSAgadd15BCL-qk1LlKjE1Yoi2gMCFt7hJrtJWiR9bn1vjnFSDRY4zBvOqR54tq6BpwvseWrpq1MhI3QuseedQa76IlnEPkHBuoUUtmvdTU5Zpyehzox5UBR8DUk2u_6afkFsOVQEgEwNbJanM-c88AyjVZn6yoieqHz7hP1jaH4_FnOG-N9j7u98PwCBzfTmI4jhP9G2VMSW4 |
linkProvider | BMJ Publishing Group Ltd |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELe2TgJeEH9HYYCRQPAwa42dOA4SQqzt1NG1oNFJewtO4nRFW1KaVNPe-A58D975OnwS7vKnowhVvOwx9iVxcufznX33O0KeO4HLeeTEzDWBBgcliJkS2maWjltOJCMeFGDPg6HsHdnvj53jNfKjzoXBsMpaJxaKOkpD3CPfQWQ7C70X9-30K8OqUXi6WpfQKMWiby7OwWXL3ux3gL8vON_rjto9VlUVYIFUKmeux0PpReCFOW7cUrqFR4ux0Z6DSCu2MgKWeNDtMkbbCRy4GJR7FGug0LGntYDnrpMNGzNaG2Rjtzv8eLjY1QEDyXMcXsEbWULuBGdfsA4WSCPHOEpboDG7Dq1LC2FRL-BfRu7fsZp_LH57t8jNymql70oxu03WTHKHXBtU5_J3yc-OOSuxrydhtk3r1Cs6LdA7k4zqJKKnaTJmuBLQdJ7DTzcZTWNaAbtmFHeEaZImv759_zRimRnjviXF9PdCeKgO57mhISIu6NkFraEW6CShYMTCc7Kc5ucpjQyG_Gevi9b2YbfzgfUv0jyl7fQEfA3Gi8FUF-IeOboS9t0nDfgW84BQwVXLtDwVBFFkS8cDy8UIi8uYu2D1aqtJXgGf_GpSZ37hLwnpVyz1kaV-ydImeYmk0xIhZDUlr9nuhxUMO1YDOV190_bipv96xy7K04IUIcSLhnQ29iuN5IPyNlKq0LU9bXNbaTD-HKlDY2tPaek0yVYtjZe_4HIWNsmzRTdoJDxm0olJ5yWNxPxr1SSbpfAuRiIEOOyWBz3uklgvDXW5J5mcFKjnrgfrD3cfrh7WU3K9Nxoc-Af7w_4jcoNjBBICEPAt0shnc_MYTMg8eFLNW0o-X7Wq-A0pi4NZ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELe2Tpp4QfynMMBIIHhY1MZJnBgJIdY_2igr09ikvWVOYndFW1KaVFPf-A58Gvg4fBLuEqejCFW87LG2k7q9893v7PPvCHnhRT5jiactX0USApRIW4EjXcuWuu0lPGFRSfa8P-S7x-6HE-9kjfys78JgWmVtE0tDnWQx7pG3kNnOxujFb2mTFnHQ7b-bfLWwghSetNblNCoVGaj5JYRv-du9Lsj6JWP93lFn1zIVBqyIB0Fh-YLFXCQQkXm-bgeyjceMWknhIeuKGygH3D3Yea4RR0Ewp8HQJ1rCCKmFlA68d51s-OAV3QbZ2OkNDw4XOzwAloTnMUN1ZDu8FV18wZpYoJkMcypdB4HtOrQuOcWydsC_AO_feZt_OML-LXLTIFj6vlK522RNpXfI5r45o79LfnTVRcWDPY7zbVpfw6KTkskzzalME3qepSMLvQLNZgUIQOU009SQvOYUd4dpmqW_vn3_fGTlaoR7mBSvwpeKRGU8KxSNkX1BTue0pl2g45QCoIX35AUtLjOaKEz_z9-UrZ3DXveTNZhnRUY72RnEHRYrJ2M-OPfI8bWI7z5pwG9RDwl1WNBWbRFEUZK43BOAYpRjM66ZDwhY2k3yGuQUmgWeh2Xs5PDQiDREkYaVSJvkFQ6dVGwhq0eyWuxhbCjZsTLI-eqHthcP_dd37KA-LYYinXjZkE1HobFOIRhyxXkQ-66QLnMDCUDQ4zJWrhSB5F6TbNXaePUXXK3IJnm-6AbrhEdOMlXZrBrD8S520CQPKuVdzMRxIHi3BfT4S2q9NNXlnnR8VjKg-wJ8EfMfrZ7WM7IJJiL8uDccPCY3GCYjIRcB2yKNYjpTTwBNFtFTs2wpOb1uS_EbO-aHhQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Demographics%2C+practice+patterns+and+long-term+outcomes+of+patients+with+non%E2%80%93ST-segment+elevation+acute+coronary+syndrome+in+the+past+two+decades%3A+the+CREDO-Kyoto+Cohort-2+and+Cohort-3&rft.jtitle=BMJ+open&rft.au=Takeji%2C+Yasuaki&rft.au=Shiomi%2C+Hiroki&rft.au=Morimoto%2C+Takeshi&rft.au=Yoshikawa%2C+Yusuke&rft.date=2021-02-22&rft.issn=2044-6055&rft.eissn=2044-6055&rft.volume=11&rft.issue=2&rft_id=info:doi/10.1136%2Fbmjopen-2020-044329&rft.externalDBID=bmjopen&rft.externalDocID=bmjopen |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2044-6055&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2044-6055&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2044-6055&client=summon |